PO.TB09.03 · 肿瘤生物学

对模拟祖先序列的系统发育与机器学习分析揭示ccRCC的异质性进化

Phylogenetic and machine learning analyses of simulated ancestral sequences reveals heterogeneous ccRCC evolution

海报缩略图:对模拟祖先序列的系统发育与机器学习分析揭示ccRCC的异质性进化
编号 707 展板 23 时间 4/19 02:00–05:00 区域 Section 28 主讲 Nic Fisk, BS;MS;PhD
分会场 Methods to Measure Tumor Evolution and Heterogeneity
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Nic Fisk1, Christopher Cross2, Brian M. Shuch3, Jeffrey Peter Townsend2

1University of Rhode Island, Kingston, RI,2Yale University, New Haven, CT,3UCLA Medical Center, Santa Monica, CA

摘要 Abstract

中文摘要
透明细胞肾细胞癌(ccRCC)占肾癌的70-80%,其发病率因影像学技术的改进、人口老龄化及肥胖率上升而不断上升。目前尚无常规诊断检测能够预测哪些小肾肿块会进展为大型侵袭性肿瘤,这留下了一个尚未解决的根本性临床问题:致命性肿瘤是以固有的侵袭性分子特征出现的,还是从惰性前体逐渐进化而来的? 为研究大小特异性的进化轨迹,我们整合了癌症效应量化、突变特征分析、系统发育重建和机器学习分类。我们使用来自TCGA-KIRC(n=339)并结合另外五项研究(总计n=656)的单核苷酸变异数据,按肿瘤大小(≤3 cm与>3 cm)分层计算了癌症效应量。我们还利用来自20例患者的多区域肿瘤测序数据,通过进行贝叶斯系统发育重建以生成时间树,来研究这些肿瘤的进化史。为表征祖先肿瘤状态,我们开发了一种新颖的二项抽样模拟方法,以变异等位基因频率为参数,生成代表可能的祖先肿瘤构型的分支中点序列状态,随后使用一个在纳入了反复出现的癌症效应量和从头突变特征权重的突变矩阵上训练的神经网络,将其分类为"小"或"大"。 我们的神经网络对ccRCC大小的分类准确率为86.48%,F1评分为0.86。在大型肿瘤患者亚组中,半数显示出类小型的祖先中点,半数显示出类大型的中点;相比之下,小型肿瘤绝大多数被分类为具有小型祖先状态,支持了模型的可靠性。我们还发现聚集在结合口袋周围的VHL突变表现出最高的癌症效应,与文献中的观察一致。有趣的是,虽然特征重要性分析识别出约1000个具有区分能力的变异,但尽管VHL在ccRCC中整体上具有重要性并可能对进化轨迹尤具影响力,在100个信息量最大的变异中只有一个VHL突变(一个截断突变)。这些结果表明ccRCC肿瘤遵循异质性的进化路径——一些大型肿瘤经历了类小型的特征状态,而另一些则没有。该框架展示了进化嵌入对机器学习分类器的实用性,并为研究祖先肿瘤特征提供了一种可推广的方法。
查看英文原文 English abstract
Clear-cell renal-cell carcinoma (ccRCC) accounts for 70-80% of kidney cancers, with increasing incidence driven by improved imaging, aging populations, and rising obesity rates. No routine diagnostic tests currently predict which small renal masses will progress to large, aggressive tumors, leaving a fundamental clinical question unresolved: do lethal tumors arise with inherently aggressive molecular characteristics, or do they gradually evolve from indolent precursors? To investigate size-specific evolutionary trajectories, we integrated cancer effect size quantification, mutational signature analysis, phylogenetic reconstruction, and machine learning classification. We calculated cancer effect sizes stratified by tumor size (≤3 cm vs >3 cm) using single-nucleotide variant data from TCGA-KIRC (n=339) combined with five additional studies (total n=656). We additionally leveraged multi-region tumor sequencing data from 20 patients to investigate the evolutionary history of these tumors by performing Bayesian phylogenetic reconstruction to generate chronograms. To characterize ancestral tumor states, we developed a novel binomial sampling simulation parameterized by variant allele frequencies to generate mid-branch sequence states representing likely ancestral tumor configurations, which were then classified as "small" or "large" using a neural network trained on mutational matrices incorporating recurrent cancer effect sizes and de novo mutational signature weights. Our neural network classified ccRCC size with 86.48% accuracy and an F1 score of 0.86. Among the patient subset with large tumors, half showed small-like ancestral midpoints while half showed large-like midpoints; in contrast, small tumors overwhelmingly classified as having small ancestral states, supporting model reliability. We also found that VHL mutations clustering around the binding pocket exhibited the highest cancer effects, supporting observations from the literature. Interestingly, while feature importance analysis identified approximately 1000 variants contributing discriminatory power, only one VHL mutation (a truncation mutation) was in the 100 most informative variants, despite VHL's overall importance in ccRCC and may be especially influential on evolutionary trajectory. These results suggest that ccRCC tumors follow heterogeneous evolutionary paths-some large tumors pass through small-like feature states while others do not. This framework demonstrates the utility of evolutionary embeddings for machine learning classifiers and offers a generalizable approach for investigating ancestral tumor characteristics.
利益披露 Disclosure
N. Fisk, None.

← 返回 AACR 2026 检索